Christopher McCormack

6PUBLICATIONS
14CO-AUTHORS
Fuzzy computationAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2025
Eight-Year Experience of Hedgehog Pathway Inhibitors at Three Tertiary Referral Centres in the Australian State of Victoria.

Christian Gan, Nicholas Manuelpillai, Peter Foley

|Nov 21, 2024
Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib.

Harmeet K Bhullar, Friyana Bhabha, Chris McCormack

|Jul 27, 2024
Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective.

Rahul Ladwa, Gerald Fogarty, Peggy Chen

|Aug 26, 2023
Patients' Experiences of Using Skin Self-monitoring Apps With People at Higher Risk of Melanoma: Qualitative Study.

Emily Habgood, Christopher McCormack, Fiona M Walter

|Sep 13, 2019
A comparative analysis of histone deacetylase inhibitors for the treatment of mycosis fungoides and Sézary syndrome.

T Papps, C McCormack, O Buelens

Pageof 1